In this global pandemic D-BSSE is capable of tackling every aspect

The startup community is hit particularly hard by the global COVID-​19 pandemic. The D-​BSSE spinoff deepCDR Biologics is making the best out of this extraordinary situation - and realises that the pandemic provides the perfect platform to showcase the deepCDR technology and antibody discovery and development. Interview with the co-​founder Derek Mason.